The Kids Research Institute
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Richmond, Peter C
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Not yet recruiting
3
9320
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
02/25
02/26
NCT05116241: Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

Completed
2
367
Europe, RoW
BPZE1 pertussis vaccine and placebo, BPZE1 pertussis vaccine and Boostrix, Placebo and Boostrix
ILiAD Biotechnologies
Bordetella Pertussis, Whooping Cough
05/24
05/24
CLO-SCB-1019-003, NCT06666179: Safety and Immunogenicity Study of SCB-1019T in Children

Withdrawn
1
112
RoW
low dose SCB-1019T, adjuvanted low dose SCB-1019T, high dose SCB-1019T, adjuvanted high dose SCB-1019T, Placebo
Clover Biopharmaceuticals AUS Pty Ltd
RSV Infection
06/26
12/26

Download Options